Condition: Cervical Intraepithelial Neoplasia-II · High Risk Human Papillomavirus · Sponsor: Zuyderland Medisch Centrum
The following hypothesis is tested: Medical grade honey in CIN II causes a higher clearance of the hr-HPV virus and an increase in the normalization of CIN II lesions compared to expectant management.
This description comes directly from the study's public registry record.
Jordy Mongula, dr. · +31621872080 · j.mongula@zuyderland.nl
Jasmijn Prop, Drs. · +31524787337 · j.prop@zuyderland.nl
Always discuss trial participation with your own doctor first.
| Zuyderland MC | Heerlen, Limburg, Netherlands | Recruiting |
| Maastricht University Medical Centre+ | Maastricht, Limburg, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06219018